STOCK TITAN

Red Violet Inc 8-K Filings

RDVT NASDAQ

Every 8-K that Red Violet Inc (RDVT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow RDVT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RDVT filings page.

Rhea-AI Summary

Red Violet, Inc. reported record second quarter 2026 results, showing strong growth in both scale and profitability. Revenue rose 23% to $26.7 million, while gross margin expanded to 76% and adjusted gross margin to 86%. Net income increased 85% to $5.0 million, and adjusted EBITDA grew 48% to $11.2 million, for a record 42% adjusted EBITDA margin. Adjusted net income reached $7.2 million, or $0.50 per diluted share.

Operating cash flow for the quarter increased 42% to a record $10.6 million, driving free cash flow of $7.2 million. Cash and equivalents were $50.0 million at June 30, 2026, before the subsequent underwritten offering that raised approximately $109.0 million in net proceeds. The company ended the quarter with 10,869 IDI billable customers after adding a record 447 in the quarter.

FOREWARN users grew by 25,493 to 443,173, with 660 REALTOR® associations contracted and a self-reported 100% association renewal rate. Management highlighted broad-based strength across four of five revenue verticals, high contractual revenue at 77% of total, gross revenue retention of 95%, no debt, and an expanding opportunity set in identity intelligence, including new expansion of FOREWARN into home healthcare and potential strategic acquisitions funded by the recent equity raise.

Rhea-AI Summary

Red Violet, Inc. completed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares sold when underwriters fully exercised their 30-day option. The shares were issued under an effective shelf registration statement at a public offering price of $60.00 per share.

The transaction generated gross proceeds of $115 million and estimated net proceeds of approximately $108.6 million after underwriting discounts, commissions, and expenses. Red Violet intends to use the net proceeds for working capital and general corporate purposes, including potential strategic acquisitions. Raymond James and Needham & Company acted as joint book-running managers.

Rhea-AI Summary

Red Violet, Inc. released estimated, unaudited preliminary results for the three months ended June 30, 2026. Revenue is expected to be $26,710 thousand, with estimated net income of $4,960 thousand.

Estimated adjusted EBITDA is $11,220 thousand, implying an adjusted EBITDA margin of 42% and a net income margin of 19%. Adjusted EBITDA is defined as net income excluding interest income, income tax expense, depreciation and amortization, share-based compensation, acquisition-related costs, litigation costs, and write-offs of long-lived assets. Management notes these figures are based on information currently available, remain subject to normal closing procedures, and have not been audited, reviewed, or compiled by Grant Thornton LLP.

Rhea-AI Summary

Red Violet, Inc. reported results from its 2026 Annual Meeting of Stockholders held on June 3, 2026. Stockholders represented 12,094,664 of the 14,112,391 common shares entitled to vote as of April 9, 2026, providing strong participation.

All five director nominees, including CEO Derek Dubner, were elected to serve until the 2027 annual meeting or until successors are chosen. Stockholders also ratified Grant Thornton LLP as independent registered public accounting firm for the year ending December 31, 2026, with 12,083,156 votes in favor and only 9,602 against.

On an advisory basis, stockholders approved 2025 compensation for named executive officers, with 8,925,718 votes for and 238,311 against, alongside 525,610 abstentions and 2,405,025 broker non-votes. These outcomes indicate general support for the company’s board, auditor selection and executive pay program.

Rhea-AI Summary

Red Violet, Inc. reported a strong first quarter of 2026 with revenue of $25.8 million, up 17% year-over-year, despite the prior-year quarter including $1.2 million of one-time revenue. Net income rose 28% to $4.4 million, or $0.30 per diluted share.

Adjusted results were even stronger. Adjusted gross profit reached $22.0 million with a record 85% adjusted gross margin, while adjusted EBITDA increased 27% to $10.7 million, a 41% margin. Adjusted net income was $6.6 million, or $0.46 per diluted share.

The company generated $6.6 million in operating cash flow and $3.1 million in free cash flow, ending the quarter with $43.5 million in cash and no debt. IDI™ billable customers grew to 10,422 and FOREWARN® users to 417,680, supporting management’s view of a sizable long-term growth opportunity, including further AI-enabled product expansion.

Rhea-AI Summary

Red Violet, Inc. reported strong fourth quarter and full-year 2025 results, highlighted by 20% revenue growth and record profitability. Full-year revenue reached $90.3 million, while GAAP diluted EPS rose to $0.91 as net income increased to $13.2 million and net margin improved to 15%.

Adjusted EBITDA for 2025 grew 31% to $31.0 million with a 34% margin, and free cash flow increased to $18.2 million. Fourth quarter revenue climbed 20% to $23.4 million, with adjusted gross margin at 83% and adjusted EBITDA margin at 25%. Cash and cash equivalents were $43.6 million at year-end.

Customer metrics also strengthened: IDI ended 2025 with 10,022 billable customers, FOREWARN reached 390,018 users, and higher-tier relationships expanded to 127 customers generating over $100,000 in annual revenue. The company repurchased 57,812 shares at an average price of $44.01 under its stock repurchase program.

Rhea-AI Summary

Red Violet, Inc. reported that on January 9, 2026 it entered into amendments to the employment agreements of its four senior leaders: Chief Executive Officer Derek Dubner, President James Reilly, Chief Financial Officer Daniel MacLachlan, and Chief Information Officer Jeffrey Dell. These amendments extend the expiration date of each executive’s employment term by approximately three years, from March 26, 2027 to March 31, 2030. The company notes that the brief description is qualified in its entirety by the full amendment texts, which are filed as exhibits to the report.

Rhea-AI Summary

Red Violet, Inc. furnished, under Regulation FD, a press release and a conference call transcript announcing financial results for the third quarter ended September 30, 2025. The company issued the materials on November 5, 2025 and provided the transcript as Exhibit 99.1.

The furnished information, including Exhibit 99.1, is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated. An Inline XBRL cover page (Exhibit 104) accompanies the filing.

Rhea-AI Summary

Red Violet, Inc. (RDVT) expanded its stock repurchase capacity, approving an additional $15.0 million under its Stock Repurchase Program, bringing total authorization to $30.0 million. As of November 3, 2025, approximately $18.9 million remained available for repurchases.

The company also furnished a press release announcing financial results for the third quarter ended September 30, 2025. The release was provided as Exhibit 99.1 and is furnished, not filed, under the Exchange Act.

Rhea-AI Summary

Red Violet, Inc. announced its financial results for the second quarter ended June 30, 2025 by furnishing a press release and a conference call transcript. The company made both documents available as exhibits to this report to communicate its second-quarter performance, and noted those materials are furnished rather than filed under the Exchange Act. The filing does not include the underlying financial statements or specific earnings figures within the 8-K text itself; the press release and call transcript are provided as Exhibits 99.1 and 99.2 for investors seeking the full results.